{"disease":{"id":"recurrent-or-refractory-igg4-related-diseases","name":"recurrent or refractory igg4 related diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07339540","title":"the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Tongji Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}